These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 813612)

  • 1. Studies on the host range specificity of pyocin P1.
    Brandis H; Krämer J; Israil A
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):13-20. PubMed ID: 813612
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of pyocin P1 on Salmonella minnesota Rd1 (proceedings)].
    Krämer J; Israil I; Brandis H
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):338-41. PubMed ID: 983521
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on a receptor for pyocin in a R mutant of Salmonella minnesota.
    Krämer J; Bradenbrink G; Brandis H
    Zentralbl Bakteriol Orig A; 1979 Jun; 243(4):457-64. PubMed ID: 113953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relations between antibiotic resistance and pyocin P3 resistance in Pseudomonas aeruginosa mutants].
    García-Quintana HG; Wilckens R
    Zentralbl Veterinarmed B; 1983 Apr; 30(3):169-74. PubMed ID: 6408850
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA; Vaughan P; Johnson D; Iglewski BH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological effects of pyocins on Salmonella typhimurium strains inoculated into the mouse].
    García-Quintana HG; Ojeda R; Mancilla JC; Chahuan E
    Zentralbl Veterinarmed B; 1983 May; 30(4):251-7. PubMed ID: 6408851
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action.
    Morse SA; Jones BV; Lysko PG
    Antimicrob Agents Chemother; 1980 Sep; 18(3):416-23. PubMed ID: 6775595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of resistance of clinical isolates of Pseudomonas aeruginosa as related to their susceptibility to phages and R-pyocins.
    Legakis N; Koukoubanis N; Malliara K; Tumah H
    Chemioterapia; 1987 Jun; 6(2 Suppl):200-1. PubMed ID: 3151342
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyocin sensitivity of pseudomonas aeruginosa pretreated with antibiotics.
    Stevens GS; Ottolenghi AC
    Can J Microbiol; 1977 May; 23(5):583-8. PubMed ID: 194663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possible use of pyocins against Pseudomonas aeruginosa (author's transl)].
    Sezen IY; Blobel H; Scharmann W
    Zentralbl Bakteriol Orig A; 1974; 229(2):205-8. PubMed ID: 4155865
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between pyocin-sensitivity and 2-amino sugar composition of Pseudomonas aeruginosa.
    Suzuki N
    FEBS Lett; 1974 Nov; 48(2):301-5. PubMed ID: 4215680
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa.
    McCaughey LC; Josts I; Grinter R; White P; Byron O; Tucker NP; Matthews JM; Kleanthous C; Whitchurch CB; Walker D
    Biochem J; 2016 Aug; 473(15):2345-58. PubMed ID: 27252387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of an S-type pyocin, pyocin AP41.
    Sano Y; Kageyama M
    J Bacteriol; 1981 May; 146(2):733-9. PubMed ID: 6783626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.